Control group | Esketamine group | P-value | |
---|---|---|---|
PHQ-9 score | |||
Before | 3.28 ± 3.15 | 3.22 ± 3.44 | 0.718 |
POD 1 | 4.03 ± 3.84 | 2.19 ± 2.75 | 0.047 |
POD 3 | 3.25 ± 2.71 | 2.56 ± 3.27 | 0.143 |
POD 7 | 3.16 ± 2.94 | 1.91 ± 2.26 | 0.100 |
POD 30 | 2.44 ± 2.94 | 1.72 ± 2.05 | 0.482 |
VAS score | |||
Before | 0.78 ± 1.58 | 0.69 ± 1.47 | 1.000 |
POD 1 | 1.22 ± 1.70 | 1.28 ± 1.97 | 0.996 |
POD 3 | 0.78 ± 1.13 | 0.75 ± 1.11 | 0.951 |
POD 7 | 0.75 ± 1.32 | 0.69 ± 1.28 | 0.994 |
POD 30 | 0.34 ± 0.75 | 0.34 ± 0.79 | 1.000 |